ETON - Company ID 0001710340
The table below shows Eton Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.84M | $19.66M | $37.12M | $25.38M | $17.42M | $20.26M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $24.89M | $13.41M | $13.08M | $14.45M | $16.40M | $5.59M |
| Inventory | $10.14M | $14.47M | $16.86M | $23.79M | $13.62M | $1.94M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $68.60M |
| $53.24M |
| $72.00M |
| $68.44M |
| $49.96M |
| $29.75M |
| Property, plant & equipment | $352.00K | $372.00K | $294.00K | $18.00K | $22.00K | $33.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $115.81M | $97.71M | $104.51M | $101.68M | $84.03M | $35.84M |
| Accounts payable | $14.40M | $13.48M | $14.26M | $12.14M | $4.87M | $2.68M |
| Total current liabilities | $45.12M | $44.18M | $44.18M | $38.60M | $25.35M | $19.73M |
| Long-term debt | $19.08M | $18.94M | $27.59M | $27.41M | $29.99M | - |
| Total liabilities | $69.22M | $67.09M | $81.38M | $77.72M | $59.58M | $19.86M |
| Retained earnings | -$99.36M | -$110.94M | -$113.98M | -$112.05M | -$109.47M | -$107.30M |
| Total equity | $46.59M | $30.61M | $23.13M | $23.96M | $24.45M | $15.98M |